Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease
- 31 August 2005
- journal article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 85 (4), 247-254
- https://doi.org/10.1016/j.ymgme.2005.03.010
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From MilkPEDIATRICS, 2004
- Recombinant human acid ??-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trialGenetics in Medicine, 2001
- Recombinant human α-glucosidase from rabbit milk in Pompe patientsThe Lancet, 2000
- Infusion of α-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry diseaseProceedings of the National Academy of Sciences of the United States of America, 2000
- Human Acid -Glucosidase from Rabbit Milk Has Therapeutic Effect in Mice with Glycogen Storage Disease Type IIHuman Molecular Genetics, 1999
- Recombinant Human Acid -Glucosidase: High Level Production in Mouse Milk, Biochemical Characteristics, Correction of Enzyme Deficiency in GSDII KO MiceHuman Molecular Genetics, 1998
- Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail.JCI Insight, 1998
- High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Isolation and Characterisation of a Recombinant, Precursor form of Lysosomal Acid α‐GlucosidaseJBIC Journal of Biological Inorganic Chemistry, 1995
- Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.Proceedings of the National Academy of Sciences of the United States of America, 1990